Parabilis Medicines, Inc. Common Stock PBLS
$26.51
+5.91%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-09-15 | View → |
| 8-K | 8-K | 2026-09-02 | View → |
| 4 | 4 | 2026-08-25 | View → |
| 8-K | 8-K | 2026-08-25 | View → |
| 10-Q | 10-Q | 2026-08-13 | View → |
| 8-K | 8-K | 2026-08-13 | View → |
| 4 | Insider transaction | 2026-07-22 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | 4 | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-15 | View → |
| 4 | 4 | 2026-06-15 | View → |
| 4 | 4 | 2026-06-15 | View → |
| 4 | 4 | 2026-06-15 | View → |
| 4 | Insider transaction | 2026-06-11 | View → |
| 4 | Insider transaction | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 8-K | 8-K | 2026-06-11 | View → |
| S-1 | S-1 | 2026-05-19 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $26.51
- Market Cap
- $3.09 billion
- 52-Week Range
- $22.66 – $42.48
- Average Volume
- 1.39 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.